Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut Bergonié
UNC Lineberger Comprehensive Cancer Center
MedImmune LLC
Inspirna, Inc.
SWOG Cancer Research Network
Roswell Park Cancer Institute
The Royal Wolverhampton Hospitals NHS Trust
Trinity Health Michigan
University of California, San Francisco
University of Washington
University of North Carolina, Chapel Hill
Alliance for Clinical Trials in Oncology
Eli Lilly and Company
Freenome Holdings Inc.
Kaiser Permanente
NantCell, Inc.
City of Hope Medical Center
Tempus AI
University of Utah
New Mexico Cancer Research Alliance
Pennington Biomedical Research Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trinity Health Michigan
NuCana plc
Elicio Therapeutics
Institut Bergonié
Academic and Community Cancer Research United
Eli Lilly and Company
Palleon Pharmaceuticals, Inc.
National Cancer Institute (NCI)
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center
Academic and Community Cancer Research United
Zhejiang University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
TheraOp
Weill Medical College of Cornell University
Hoffmann-La Roche
UNC Lineberger Comprehensive Cancer Center
Swiss Cancer Institute
University of Florida
NRG Oncology
Jilin University
University of Florida
NuCana plc
Black Diamond Therapeutics, Inc.